Advertisement
IDXX vs STE
Which Stock Would AI Choose? IDEXX Laboratories (IDXX) vs. STERIS (STE) Stock Comparison
Key Takeaways
- IDXX and STE operate in distinct healthcare niches—veterinary diagnostics for IDXX and infection prevention products for STE—offering investors exposure to different growth drivers within the sector.
- Recent market activity shows both stocks navigating broader healthcare sector dynamics, with performance influenced by macroeconomic factors and company-specific fundamentals.
- IDXX benefits from steady demand in companion animal health, while STE leverages recurring revenue from sterilization and procedural support services.
- Relative performance over recent weeks reflects contrasting momentum patterns, with sector sentiment playing a key role in price behavior.
- Risk profiles differ due to varying exposure to regulatory environments, supply chains, and end-market stability.
- Market positioning highlights trade-offs between growth-oriented veterinary innovation and established medical technology infrastructure.
Introduction
This comparison examines IDXX and STE to provide traders and investors with insights into how these healthcare stocks stack up in the current environment. Both companies serve specialized medical needs but target different customer bases and face unique operational considerations. The analysis appeals to those evaluating sector allocation, relative momentum, and risk-adjusted positioning within healthcare equities. Readers interested in data-driven perspectives on business models, recent trends, and market sentiment will find the review particularly relevant for portfolio construction decisions.
IDXX Overview and Recent Performance
IDEXX Laboratories, Inc. develops and distributes diagnostic products and software primarily for the companion animal veterinary market, along with offerings in livestock, water testing, and dairy sectors. The company maintains a global presence and focuses on tools that support veterinary practices with rapid, accurate testing solutions. In recent weeks, IDXX has exhibited measured stock behavior amid steady demand for pet healthcare services. Sentiment has been shaped by consistent operational execution and broader market interest in animal health innovation, contributing to relatively stable positioning despite sector-wide fluctuations.
STE Overview and Recent Performance
STERIS plc provides infection prevention products, sterilization services, and procedural support solutions primarily to healthcare facilities and life sciences customers. The company emphasizes recurring revenue streams from consumables and services tied to medical procedures. Recent market activity for STE has reflected resilience in core segments, with performance influenced by procedural volume trends and cost management efforts. Sentiment remains tied to healthcare utilization patterns and operational efficiencies, resulting in performance that tracks broader medical technology dynamics over recent weeks.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from a larger pool. Tickeron offers hundreds of AI Trading Bots that trade thousands of different tickers, yet only the strongest and most suitable for prevailing market conditions earn placement in this curated section. The platform currently highlights its Best AI Trending Bots (25) Selected out of 351 Total, showcasing varied trading styles, strategies, timeframes, performance metrics, and ticker sets. These bots differ widely in approach and results, allowing users to explore options aligned with specific objectives. Explore the full range of available robots and strategies on the Trending AI Robots page for additional details.
Head-to-Head Comparison
IDEXX Laboratories and STERIS operate in complementary yet distinct areas of healthcare. IDXX centers on veterinary diagnostics and software with growth tied to pet ownership trends and diagnostic adoption, whereas STE focuses on infection prevention and sterilization with emphasis on procedural volume and service contracts. Business models contrast recurring diagnostic revenue for IDXX against service-oriented recurring streams for STE. Recent momentum has shown differing sensitivities to sector catalysts, with IDXX reflecting veterinary market steadiness and STE influenced by hospital and procedural activity. Risk factors include regulatory oversight for both, though STE faces additional considerations around healthcare facility spending cycles. Sector exposure places IDXX more squarely in animal health while STE aligns with broader medical devices and services. Market sentiment for each has responded to unique end-market signals rather than uniform healthcare trends.
Tickeron AI Verdict
Based on observable factors such as trend consistency in core segments, stability of demand drivers, and relative positioning within healthcare subsectors, Tickeron’s AI would currently assign a modestly higher probability of favorable near-term characteristics to IDXX. This assessment reflects steadier sentiment patterns and alignment with resilient end-market demand observed in recent activity, though outcomes remain subject to evolving market conditions and company execution.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and STE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IDXX’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).
- IDXX’s FA Score: 1 green, 4 red.
- STE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IDXX’s TA Score shows that 5 TA indicator(s) are bullish while STE’s TA Score has 6 bullish TA indicator(s).
- IDXX’s TA Score: 5 bullish, 4 bearish.
- STE’s TA Score: 6 bullish, 4 bearish.
Price Growth
IDXX (@Medical Specialties) experienced а +2.71% price change this week, while STE (@Medical/Nursing Services) price change was +6.69% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.40%. For the same industry, the average monthly price growth was -3.39%, and the average quarterly price growth was +6.80%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.50%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -17.67%.
Reported Earning Dates
IDXX is expected to report earnings on Aug 04, 2026.
STE is expected to report earnings on Aug 10, 2026.
Industries' Descriptions
@Medical Specialties (+0.40% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+2.50% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| IDXX | STE | IDXX / STE | |
| Capitalization | 44.1B | 22.3B | 198% |
| EBITDA | 1.56B | 1.59B | 98% |
| Gain YTD | -17.362 | -9.411 | 184% |
| P/E Ratio | 41.14 | 28.80 | 143% |
| Revenue | 4.45B | 5.94B | 75% |
| Total Cash | 201M | N/A | - |
| Total Debt | 1.11B | 2.09B | 53% |
IDXX | STE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 79 | |
SMR RATING 1..100 | 16 | 67 | |
PRICE GROWTH RATING 1..100 | 57 | 49 | |
P/E GROWTH RATING 1..100 | 69 | 76 | |
SEASONALITY SCORE 1..100 | 50 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STE's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for IDXX (78). This means that STE’s stock grew significantly faster than IDXX’s over the last 12 months.
STE's Profit vs Risk Rating (79) in the Medical Specialties industry is in the same range as IDXX (100). This means that STE’s stock grew similarly to IDXX’s over the last 12 months.
IDXX's SMR Rating (16) in the Medical Specialties industry is somewhat better than the same rating for STE (67). This means that IDXX’s stock grew somewhat faster than STE’s over the last 12 months.
STE's Price Growth Rating (49) in the Medical Specialties industry is in the same range as IDXX (57). This means that STE’s stock grew similarly to IDXX’s over the last 12 months.
IDXX's P/E Growth Rating (69) in the Medical Specialties industry is in the same range as STE (76). This means that IDXX’s stock grew similarly to STE’s over the last 12 months.
| IDXX | STE | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 53% |
| Stochastic ODDS (%) | 4 days ago 69% | 4 days ago 59% |
| Momentum ODDS (%) | 4 days ago 67% | 4 days ago 53% |
| MACD ODDS (%) | 4 days ago 66% | 4 days ago 61% |
| TrendWeek ODDS (%) | 4 days ago 59% | 4 days ago 52% |
| TrendMonth ODDS (%) | 4 days ago 53% | 4 days ago 47% |
| Advances ODDS (%) | 6 days ago 58% | 6 days ago 48% |
| Declines ODDS (%) | 12 days ago 70% | 4 days ago 57% |
| BollingerBands ODDS (%) | 4 days ago 62% | 4 days ago 69% |
| Aroon ODDS (%) | 4 days ago 70% | 4 days ago 49% |
Advertisement
IDXX and
Correlation & Price change
A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with ALGN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then ALGN could also see price increases.
| Ticker / NAME | Correlation To IDXX | 1D Price Change % | ||
|---|---|---|---|---|
| IDXX | 100% | +0.05% | ||
| ALGN - IDXX | 50% Loosely correlated | -2.45% | ||
| SYK - IDXX | 48% Loosely correlated | -6.42% | ||
| BLCO - IDXX | 45% Loosely correlated | -0.47% | ||
| SNN - IDXX | 44% Loosely correlated | -2.38% | ||
| STE - IDXX | 40% Loosely correlated | -1.22% | ||
More | ||||